Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Full textbook

Safe procedural sedation

Plan and deliver adult procedural sedation within a defined target depth, with competent staffing, proportionate monitoring and immediate rescue capability if consciousness, airway control or ventilation deteriorates.

Saved on this device
!
Sedation is deeper than intended

Loss of verbal response, airway obstruction, apnoea, desaturation, hypotension or paradoxical agitation can signal unintended deep sedation or another acute complication.

Action: Stop sedative administration and procedural stimulation where possible, call for help, open the airway, give oxygen, support effective ventilation and circulation, use relevant reversal cautiously and escalate to advanced airway management when recovery is not prompt.

Open the sections you need. The overview is shown first.
01Core principlesThe concepts and mechanisms needed to understand the subject.

Minimal sedation preserves normal response to verbal command. Moderate sedation preserves purposeful response to verbal or light tactile stimulation, usually without airway intervention. During deep sedation, purposeful response occurs only after repeated or painful stimulation and airway or ventilation support may be required. General anaesthesia produces unresponsiveness even to painful stimulation. Individual response is unpredictable, so a planned dose cannot guarantee a particular level.

Safety begins by matching the intended state to the patient, procedure, setting and team. Pre-assessment identifies airway difficulty, cardiorespiratory disease, frailty, sleep apnoea, hepatic or renal impairment, previous adverse events and interacting medicines. Consent covers alternatives, the intended experience, possibility of recall, material complications and the possibility that sedation may need to stop or convert to anaesthesia.

Drug combinations increase risk. An opioid plus a benzodiazepine can produce more respiratory depression than either alone, and peak effect may lag behind injection. Titrate one small dose at a time and wait long enough to assess effect before redosing. Older, frail or organ-impaired adults generally need smaller doses and longer intervals. Reversal agents supplement airway and ventilatory rescue; they do not replace it.

Monitoring should detect depth, obstruction and impaired ventilation early. All sedation requires clinical observation and at least pulse oximetry; national guidance adds ECG, automated blood pressure and capnography for deeper-than-minimal sedation. A normal oxygen saturation on supplemental oxygen cannot exclude apnoea or carbon dioxide retention. Documentation should allow reconstruction of observations, doses, response, complications and recovery.

Key points

  • Sedation is a continuum: if targeting moderate sedation, the team must be able to rescue a patient who becomes deeply sedated; deep sedation requires capability to rescue from general anaesthesia.
  • For sedation deeper than minimal, use pulse oximetry, ECG, automated blood pressure and continuous waveform capnography, while directly observing airway, breathing, circulation and responsiveness.
  • Stop drugs and rescue immediately when verbal responsiveness is lost unexpectedly, the airway obstructs or ventilation becomes ineffective; give oxygen and verify assisted breaths by chest movement and waveform capnography.
  • Pre-assess comorbidity, airway, prior sedation problems, medicines, substance use, pregnancy possibility where relevant, fasting status and the procedure’s pain, duration and positioning.
  • Except for brief minimal sedation, provide a dedicated trained monitor with no competing task and enough staff to perform the procedure while managing complications.
  • This adult framework does not set paediatric, obstetric, intensive-care or specialty-specific drug regimens; those populations require trained teams and their own governance.
02Mechanisms and patternsImportant relationships and how to distinguish them.
Minimal sedation

The patient responds normally to verbal commands with unaffected ventilation and cardiovascular function.

Moderate sedation

Purposeful response remains to verbal or light tactile stimulation; spontaneous ventilation is usually adequate.

Deep sedationRed flag

Purposeful response requires repeated or painful stimulation, and airway intervention or ventilatory support may be needed.

Airway obstructionRed flag

Snoring, tracheal tug, paradoxical movement or absent airflow despite effort indicates obstruction and requires immediate airway action.

Apnoea or hypoventilationRed flag

A falling respiratory rate, shallow movement or absent or changing carbon dioxide waveform may precede desaturation.

Paradoxical reaction

Agitation or disinhibition after a sedative should prompt safety measures and assessment for hypoxia, pain, delirium and drug effect.

Red flags requiring action

  • Loss of normal verbal response during intended moderate sedation means the patient has crossed into deeper sedation and needs immediate rescue assessment.
  • Snoring obstruction, paradoxical breathing, absent chest movement or a flat capnography trace requires prompt airway manoeuvres and confirmation of effective ventilation.
  • Apnoea, persistent desaturation, hypotension, arrhythmia or reduced responsiveness demands cessation of drug delivery and structured resuscitation.
  • Repeated small doses can accumulate, especially in older or frail adults and after opioids, alcohol or other central nervous system depressants.
  • A procedure cannot safely continue when the only person able to monitor and rescue the patient is occupied by the technical task.
  • Discharge before recovery of baseline consciousness, stable observations and safe mobility can expose the patient to recurrent drug effect away from monitoring.
03Interpreting evidenceInformation, measurements and their limitations.
Reasoning sequence

Consider the information, its meaning and its limitations before deciding what follows.

  1. 01
    Pre-sedation airway assessment
    Why
    Identify features that may make airway opening, bag-mask ventilation or tracheal intubation difficult.
    Interpretation and limitations
    Predicted difficulty changes personnel, location, technique and the threshold for anaesthetic involvement; it does not reliably predict every event.
  2. 02
    Continuous waveform capnography
    Why
    Detect apnoea, obstruction and declining ventilation earlier than pulse oximetry alone.
    Interpretation and limitations
    An absent or altered waveform prompts immediate inspection of the patient and equipment; oxygenation and ventilation remain separate assessments.
  3. 03
    Sedation-depth assessment
    Why
    Confirm that responsiveness remains within the intended level throughout the procedure.
    Interpretation and limitations
    Loss of expected verbal response means deeper sedation and activates the corresponding rescue capability and staffing requirement.
  4. 04
    Medicine and substance history
    Why
    Identify prescribed, over-the-counter and recreational agents that alter sedative effect or recovery.
    Interpretation and limitations
    Opioids, alcohol and other central depressants can amplify effect; hepatic or renal disease may prolong exposure.
  5. 05
    Fasting and aspiration-risk review
    Why
    Plan moderate or deep sedation and identify conditions that increase aspiration consequence.
    Interpretation and limitations
    Fasting is recommended for elective moderate or deep sedation, but urgent care uses an individual risk-benefit decision and an airway rescue plan rather than an automatic delay.
04Applied reasoningWorked examples connecting principles to decisions.
01Worked case: intended moderate sedationPlanning sedation for a painful procedureA stable adult needs a painful procedure and is expected to retain purposeful response to voice.
  1. 1Define the intended moderate depth, assess patient and airway risk, explain alternatives and material risks, and confirm fasting and medicine history appropriate to the urgency.
  2. 2Allocate a trained dedicated monitor, prepare oxygen, suction, airway and resuscitation equipment, and attach pulse oximetry, ECG, automated blood pressure and waveform capnography.
  3. 3Titrate small drug doses with time for peak effect, assess verbal response and ventilation after each dose, and pause if the patient approaches a deeper level.
  4. 4Continue observation until baseline consciousness and stable physiology return, apply written discharge criteria and give escort and activity advice after ambulatory care.
02Sedation emergencyUnintended deep sedation with ineffective ventilationThe patient stops responding to voice, obstructs and has little chest movement after combined sedative and opioid doses.
  1. 1Stop drug administration, call for help, stop the procedure if safe, open and suction the airway as needed, and give high-concentration oxygen.
  2. 2Provide assisted ventilation when breathing is inadequate and confirm actual effectiveness from chest rise, capnography, airway pressure and leak; progress to supraglottic or tracheal airway management if needed.
  3. 3Support circulation and consider titrated agent-specific reversal without delaying airway care, recognising recurrence when the sedative or opioid outlasts the antagonist.
  4. 4After stabilisation, extend monitored recovery, document the event and change the discharge or admission plan according to ongoing risk.
03Recovery decisionDischarge after ambulatory sedationThe procedure is complete and the patient asks to leave soon after the last dose.
  1. 1Confirm return toward baseline consciousness, stable airway, breathing and circulation, controlled symptoms and safe mobilisation under written criteria.
  2. 2Review the drug timing and likelihood of recurrent effect, arrange a responsible escort where required and provide written restrictions and emergency contacts.
  3. 3Record observations, drug doses, adverse events, discharge assessment and the person receiving aftercare information.
05Relevant medicines and safetySpecific regimens and precautions where medicines are relevant.
Provides anxiolysis, amnesia and sedation for selected procedures.

Midazolam

Give small titrated intravenous doses with adequate time between increments; use lower and slower dosing in older or frail adults.

Can cause airway obstruction and respiratory depression, especially with opioids; delayed effect makes rapid repeat dosing hazardous.

Treats painful stimulation that a hypnotic or anxiolytic alone does not address.

Opioid adjunct

Use the smallest titrated dose needed for procedural pain, allowing for onset and interaction with other sedatives.

Synergistic ventilatory depression occurs with sedatives; have naloxone and airway rescue capability immediately available.

Partially reverses a defined drug effect while supportive care continues.

Reversal agents

Titrate naloxone for opioid effect or flumazenil for selected benzodiazepine toxicity according to local protocol.

Re-sedation can occur; flumazenil may precipitate seizures or withdrawal in susceptible patients, and neither drug replaces effective ventilation.

06Checking understandingVerify the reasoning, revisit uncertainties and apply feedback.
  • Before dosing, document baseline consciousness, respiratory rate, oxygen saturation, pulse and blood pressure and attach monitoring appropriate to intended depth.
  • For deeper-than-minimal sedation, monitor ECG, automated blood pressure, pulse oximetry and continuous waveform capnography alongside direct observation.
  • Record responsiveness and each drug, dose and time so a change in depth can be related to accumulating effect.
  • Keep monitoring during recovery until the patient returns toward baseline and no longer needs airway or circulatory support.
  • Use the same vigilance during repositioning and transfer, when airway access can worsen and monitoring can be disconnected.
07Special situationsVariants, exceptions and circumstances that change the usual approach.

Depth is an observed state

A dose label does not make sedation moderate; the patient’s response and need for airway support define the actual level.

Capnography buys time

Carbon dioxide waveform change can identify apnoea while supplemental oxygen still preserves saturation.

Reversal has a clock

An antagonist may wear off before the sedative, so recovery observations must continue after apparent improvement.

Staffing is treatment

A dedicated observer can recognise declining responsiveness while the proceduralist remains occupied.

Context changes competence

Deep sedation, paediatrics, pregnancy, frailty and remote sites need specific expertise, governance and rescue arrangements.

08Common pitfallsFrequent interpretation and management errors.
  1. 01

    Assuming an intended moderate dose prevents the patient entering deep sedation.

  2. 02

    Relying on oxygen saturation alone when oxygen may delay recognition of apnoea.

  3. 03

    Giving repeated boluses before the preceding dose reaches peak effect.

  4. 04

    Allowing the only trained monitor to perform the procedure simultaneously.

  5. 05

    Using naloxone or flumazenil as a substitute for airway opening and effective assisted ventilation.

  6. 06

    Discharging soon after apparent awakening without considering recurrent sedation and written aftercare.

Practice

Two practice questions

Question 1 of 20 correct
Anaesthetics and perioperativeOriginal SBA

Rescue capability for moderate sedation

A team plans moderate sedation for an adult procedure. Which capability must be present even though deep sedation is not intended?

Sources and review status3 sources · checked 13 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 13 Sept 2026; clinical approval remains outstanding.

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom